Standard Prophylactic Versus Intermediate Dose Enoxaparin in Adults with Severe COVID-19: A Multi-Center, Open-Label, Randomised Controlled Trial
SSRN Electronic Journal (2021) - Comments
doi: 10.2139/ssrn.3840099  issn: 1556-5068 

Usha Perepu, Isaac Chambers, Abdul Wahab, Patrick Ten Eyck, Chaorong Wu, Sanjana Dayal, Grerk Sutamtewagul, Steven R. Bailey, Lori J. Rosenstein, Steven R. Lentz